Holo-lipocalin-2–derived siderophores increase mitochondrial ROS and impair oxidative phosphorylation in rat cardiomyocytes
- 29 January 2018
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (7) , 1576-1581
Abstract
Lipocalin-2 (Lcn2), a critical component of the innate immune response which binds siderophores and limits bacterial iron acquisition, can elicit spillover adverse proinflammatory effects. Here we show that holo-Lcn2 (Lcn2–siderophore–iron, 1:3:1) increases mitochondrial reactive oxygen species (ROS) generation and attenuates mitochondrial oxidative phosphorylation in adult rat primary cardiomyocytes in a manner blocked by N-acetyl-cysteine or the mitochondria-specific antioxidant SkQ1. We further demonstrate using siderophores 2,3-DHBA (2,3-dihydroxybenzoic acid) and 2,5-DHBA that increased ROS and reduction in oxidative phosphorylation are direct effects of the siderophore component of holo-Lcn2 and not due to apo-Lcn2 alone. Extracellular apo-Lcn2 enhanced the potency of 2,3-DHBA and 2,5-DHBA to increase ROS production and decrease mitochondrial respiratory capacity, whereas intracellular apo-Lcn2 attenuated these effects. These actions of holo-Lcn2 required an intact plasma membrane and were decreased by inhibition of endocytosis. The hearts, but not serum, of Lcn2 knockout (LKO) mice contained lower levels of 2,5-DHBA compared with wild-type hearts. Furthermore, LKO mice were protected from ischemia/reperfusion-induced cardiac mitochondrial dysfunction. Our study identifies the siderophore moiety of holo-Lcn2 as a regulator of cardiomyocyte mitochondrial bioenergetics. Significance Metabolic dysfunction associated with decreased mitochondrial oxidative capacity is a major underlying cause of heart failure. Our study sheds new light on the potential role of bacteria-derived or endogenous siderophores as direct regulators of cardiomyocyte mitochondrial function. Furthermore, we demonstrate that lipocalin-2, a key feature of the innate immune response, facilitates the transport of siderophore–iron complexes into cells. This mechanism may have important physiological implications because elevated lipocalin-2 levels correlate positively with heart failure in humans, and mice lacking lipocalin-2 are protected from stress-induced mitochondrial dysfunction and heart failure.Keywords
Funding Information
- Heart and Stroke Foundation of Canada (N/A)
- Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (436138-2013)
- James H. Cummings Foundation (N/A)
- Gouvernement du Canada | Canadian Institutes of Health Research (CIHR; FDN-143219)
This publication has 42 references indexed in Scilit:
- Cardiac Metabolism in Heart FailureCirculation Research, 2013
- Lipocalin-2 (24p3/Neutrophil Gelatinase-associated Lipocalin (NGAL)) Receptor Is Expressed in Distal Nephron and Mediates Protein EndocytosisJournal of Biological Chemistry, 2012
- Production and Detection of Reactive Oxygen Species (ROS) in CancersJournal of Visualized Experiments, 2011
- Lipocalin‐2 deficiency prevents endothelial dysfunction associated with dietary obesity: role of cytochrome P450 2C inhibitionBritish Journal of Pharmacology, 2011
- A Mammalian Siderophore Synthesized by an Enzyme with a Bacterial Homolog Involved in Enterobactin ProductionCell, 2010
- Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosolProceedings of the National Academy of Sciences, 2010
- Functional and Mechanistic Integration of Infection and the Metabolic SyndromeKorean Diabetes Journal, 2010
- Siderophore-Based Iron Acquisition and Pathogen ControlMicrobiology and Molecular Biology Reviews, 2007
- Lipocalin-2 Is an Inflammatory Marker Closely Associated with Obesity, Insulin Resistance, and Hyperglycemia in HumansClinical Chemistry, 2007
- The Neutrophil Lipocalin NGAL Is a Bacteriostatic Agent that Interferes with Siderophore-Mediated Iron AcquisitionMolecular Cell, 2002